Crossmark

A cluster-randomized, non-inferiority trial comparing use of misoprostol for universal prophylaxis vs. secondary prevention of postpartum hemorrhage among community level births in Egypt

Crossref DOI link: https://doi.org/10.1186/s12884-020-03008-5

Published Online: 2020-05-24

Published Print: 2020-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Anger, Holly A. https://orcid.org/0000-0002-0042-4925
Dabash, Rasha

Hassanein, Nevine

Darwish, Emad

Ramadan, Mohamed Cherine

Nawar, Medhat

Charles, Dyanna

Breebaart, Miral

Winikoff, Beverly
Funding

Funding for this research was provided by:

Bill and Melinda Gates Foundation (NA)
License Information

Text and Data Mining valid from 2020-05-24

Version of Record valid from 2020-05-24
More Information

Article History

Received: 20 August 2018

Accepted: 11 May 2020

First Online: 24 May 2020

Ethics approval and consent to participate

: This protocol was approved by the ethics committee at the Alexandria University Faculty of Medicine (IRB NO: 00007555, FWA NO: 0001572). All participants provided written, informed consent before participation in the study. The minimum age of participants included in the analysis was 16.

: Not applicable.

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below